Enhancement of protective immune responses to Venezuelan equine encephalitis (VEE) virus with microencapsulated vaccine

By Ludwig G.   Smith J.F.   Greenway T.E.   Eldridge J.H.   Staas J.K.   Gilley R.M.   Michalek S.M.  

Vaccine, Vol. 13, Iss. 15, 1995-01 ,pp. : 1411-1420

Elsevier

Access to resources Recommend Favorite

Localization of a protective epitope on a Venezuelan equine encephalomyelitis (VEE) virus peptide that protects mice from both epizootic and enzootic VEE virus challenge and is immunogenic in horses

By Hunt A.R.   Roehrig J.T.  

Vaccine, Vol. 13, Iss. 3, 1995-01 ,pp. : 281-288

Elsevier

Access to resources Recommend Favorite

TC-83 vaccine protects against airborne or subcutaneous challenge with heterologous mouse-virulent strains of Venezuelan equine encephalitis virus

By Phillpotts R.J.   Wright A.J.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 982-988

Elsevier

Access to resources Recommend Favorite

Use of telemetry to assess vaccine-induced protection against parenteral and aerosol infections of Venezuelan equine encephalitis virus in non-human primates

By Pratt W.D.   Gibbs P.   Pitt M.L.M.   Schmaljohn A.L.  

Vaccine, Vol. 16, Iss. 9, 1998-05 ,pp. : 1056-1064

Elsevier

Access to resources Recommend Favorite

Evaluation of Venezuelan Equine Encephalitis (VEE) replicon-based Outer surface protein A (OspA) vaccines in a tick challenge mouse model of Lyme disease

By Gipson C.L.   Davis N.L.   Johnston R.E.   de Silva A.M.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3875-3884

Elsevier

Access to resources Recommend Favorite